# ST Pharm signs KRW 16.7B API supply deal with European diagnostics firm

ST Pharm announced a KRW 16.7 billion contract to supply generic MRI contrast agent active pharmaceutical ingredients to a European medical diagnostics equipment company.

- Type: Contract
- Announced: 2019-08-23
- Value: $13.9M (16.7B KRW)
- Status: completed
- Products: generic MRI contrast agent active pharmaceutical ingredients
- Sectors: [Specialty Chemicals](https://endata.com/sectors/specialty-chemicals.md)

## Companies

- [ST Pharm](https://endata.com/companies/41553.md)

## Sources

- [asiae.co.kr](https://www.asiae.co.kr/article/2019082315065452309), 2019-08-23: "에스티팜은 유럽 소재 글로벌 의료진단 장비 제조회사와 167억원 규모의 자기공명영상(MRI) 조영제 제네릭 원료의약품 공급 계약을 체결했다고 23일 공시했다."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.